Longitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing

Journal of Genetic Counseling

Volumn 23, Issue 1, 2014, Pages 97-107

  Pastore, Lisa M ^a,d   Karns, Logan B ^a   Ventura, Karen ^a   Clark, Myra L ^b   Steeves, Richard H ^b   Callanan, Nancy ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^d NONE   (United States)

Author keywords

Decision making; Diminished ovarian reserve; Female infertility; FMR1; Fragile X; Genetic counseling; Genetic testing; Qualitative research

Indexed keywords

ADULT; ARTICLE; FEMALE; FRAGILE X SYNDROME; GENETICS; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MUTATION;

ADULT; FEMALE; FRAGILE X SYNDROME; HUMANS; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MUTATION;

EID: 84897610166     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-013-9616-0     Document Type: Article

References (53)

1. ACOG Committee of Genetics. (2010). Carrier screening for fragile X syndrome. Obstetrics and Gynecology, 116(4), 1008-1010.
2. Agar, M. H. (1986). Speaking of ethnography. Beverly Hills: Sage.
3. Akande, V. A.; Fleming, C. F.; Hunt, L. P.; Keay, S. D.; & Jenkins, J. M. (2002). Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Human Reproduction, 17(8), 2003-2008.
4. Anido, A.; Carlson, L. M.; Taft, L.; & Sherman, S. (2005). Women's attitudes toward testing for fragile X carrier status: a qualitative analysis. Journal of Genetic Counseling, 14(4), 295-306.
5. Archibald, A. D.; & McClaren, B. J. (2012). Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making. Journal of Community Genetics, 3(1), 47-54.
6. Ashley-Koch, A. E.; Robinson, H.; Glicksman, A. E.; Nolin, S. L.; Schwartz, C. E.; Brown, W. T.; et al. (1998). Examination of factors associated with instability of the FMR1 CGG repeat. American Journal of Human Genetics, 63(3), 776-785.
7. Bitler, M.; & Schmidt, L. (2006). Health disparities and infertility: impacts of state-level insurance mandates. Fertility and Sterility, 85(4), 858-865.
8. Brown, W. T.; Houck, G. E.; Jr.; Ding, X.; Zhong, N.; Nolin, S.; Glicksman, A.; et al. (1996). Reverse mutations in the fragile X syndrome. American Journal of Medical Genetics, 64(2), 287-292.
9. Cohen, M. Z.; Kahn, D. L.; & Steeves, R. H. (2000). Hermeneutic phenomenology: a practical guide for nurse researchers. Thousand Oaks: Sage.
10. Decruyenaere, M.; Evers-Kiebooms, G.; Boogaerts, A.; Cassiman, J. J.; Cloostermans, T.; Demyttenaere, K.; et al. (1996). Prediction of psychological functioning 1 year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making. Journal of Medical Genetics, 33(9), 737-743.
11. Decruyenaere, M.; Evers-Kiebooms, G.; Boogaerts, A.; Demyttenaere, K.; Dom, R.; & Fryns, J. (2005). Partners of mutation-carriers for Huntington's disease: forgotten persons? European Journal of Human Genetics, 13(9), 1077-1085.
12. Decruyenaere, M.; Evers-Kiebooms, G.; Boogaerts, A.; Philippe, K.; Demyttenaere, K.; Dom, R.; et al. (2007). The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. European Journal of Human Genetics, 15(4), 453-462.
13. Finucane, B.; Abrams, L.; Cronister, A.; Archibald, A.; Bennett, R.; & McConkie-Rosell, A. (2012). Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the National Society of Genetic Counselors. Journal of Genetic Counseling. doi: 10.1007/s10897-012-9524-8.
14. Fisch, G. S.; Snow, K.; Thibodeau, S. N.; Chalifaux, M.; Holden, J. J.; Nelson, D. L.; et al. (1995). The fragile X premutation in carriers and its effect on mutation size in offspring. American Journal of Human Genetics, 56(5), 1147-1155.
15. Friese, C.; Becker, G.; & Nachtigall, R. D. (2006). Rethinking the biological clock: eleventh-hour moms, miracle moms and meanings of age-related infertility. Social Science & Medicine, 63(6), 1550-1560.
16. Gadamer, H.-G. (1989). Truth and method (J. W. D. G. Marshall, Trans. 2nd ed.). NY: Crossroads.
17. Gleicher, N.; Weghofer, A.; & Barad, D. H. (2009). A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertility and Sterility, 91(5), 1700-1706.
18. Glover, L.; McLellan, A.; & Weaver, S. M. (2009). What does having a fertility problem mean to couples? Journal of Reproductive & Infant Psychology, 27(4), 401-418.
19. Greil, A. L.; Slauson-Blevins, K.; & McQuillan, J. (2010). The experience of infertility: a review of recent literature. Sociology of Health & Illness, 32(1), 140-162.
20. Heidegger, M. (1962). Being and time (J. M. E. Robinson, Trans.). NY: Harper and Row.
21. Imeson, M.; & McMurray, A. (1996). Couples' experiences of infertility: a phenomenological study. Journal of Advanced Nursing, 24(5), 1014-1022.
22. Karimov, C. B.; Moragianni, V. A.; Cronister, A.; Srouji, S.; Petrozza, J.; Racowsky, C.; et al. (2011). Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Human Reproduction, 26(8), 2077-2083.
23. Kenen, R.; Smith, A. C. M.; Watkins, C.; & Zuber-Pittore, C. (2000). To use or not to use: male partners' perspectives on decision making about prenatal diagnosis. Journal of Genetic Counseling, 9(1), 33-45.
24. Kockelmanns, J. J. (1975). Towards an interpretive or hermeneutic social science. Graduate Faculty Philosophy Journal: New School of Social Research, 5(1), 73-96.
25. Levi, A. J.; Raynault, M. F.; Bergh, P. A.; Drews, M. R.; Miller, B. T.; & Scott, R. T.; Jr. (2001). Reproductive outcome in patients with diminished ovarian reserve. Fertility and Sterility, 76(4), 666-669.
26. Lincoln, Y. S.; & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills: Sage.
27. McCarthy, M. P. (2008). Women's lived experience of infertility after unsuccessful medical intervention. Journal of Midwifery & Women's Health, 53(4), 319-324.
28. McConkie-Rosell, A.; Finucane, B.; Cronister, A.; Abrams, L.; Bennett, R. L.; & Pettersen, B. J. (2005). Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors. Journal of Genetic Counseling, 14(4), 249-270.
29. McConkie-Rosell, A.; Abrams, L.; Finucane, B.; Cronister, A.; Gane, L. W.; Coffey, S. M.; et al. (2007). Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. Journal of Genetic Counseling, 16(5), 593-606.
30. Nachtigall, R. D.; MacDougall, K.; Davis, A. C.; & Beyene, Y. (2012). Expensive but worth it: older parents' attitudes and opinions about the costs and insurance coverage for in vitro fertilization. Fertility and Sterility, 97(1), 82-87.
31. Nelson, L. M.; & Bakalov, V. K. (2003). Mechanisms of follicular dysfunction in 46, XX spontaneous premature ovarian failure. Endocrinology and Metabolism Clinics of North America, 32, 613-637.
32. Nolin, S. L.; Lewis, F. A.; 3rd, Ye, L. L.; Houck, G. E.; Jr.; Glicksman, A. E.; Limprasert, P.; et al. (1996). Familial transmission of the FMR1 CGG repeat. American Journal of Human Genetics, 59(6), 1252-1261.
33. Nolin, S. L.; Brown, W. T.; Glicksman, A.; Houck, G. E.; Jr.; Gargano, A. D.; Sullivan, A.; et al. (2003). Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. American Journal of Human Genetics, 72(2), 454-464.
34. Nolin, S. L.; Glicksman, A.; Ding, X.; Ersalesi, N.; Brown, W. T.; Sherman, S. L.; et al. (2011). Fragile X analysis of 1112 prenatal samples from 1991-2010. Prenatal Diagnosis, 31(10), 925-931.
35. Nolin, S. L.; Sah, S.; Glicksman, A.; Sherman, S. L.; Allen, E.; Berry-Kravis, E.; et al. (2013). Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. American Journal of Medical Genetics. Part A, 161(4), 771-778.
36. Pastore, L. M.; Karns, L. B.; Pinkerton, J. V.; Silverman, L. M.; Williams, C. D.; & Camp, T. R. (2006). Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction. American Journal of Obstetrics and Gynecology, 194(3), 738-743.
37. Pastore, L. M.; Morris, W. L.; Karns, L. B.; Pastore, L. M.; Morris, W. L.; & Karns, L. B. (2008). Emotional reaction to fragile X premutation carrier tests among infertile women. Journal of Genetic Counseling, 17(1), 84-91.
38. Pastore, L. M.; Young, S. L.; Baker, V. M.; Karns, L. B.; Williams, C. D.; & Silverman, L. M. (2012). Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reproductive Sciences, 19(11), 1226-1231.
39. Reyniers, E.; Vits, L.; De Boulle, K.; Van Roy, B.; Van Velzen, D.; de Graaff, E.; et al. (1993). The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nature Genetics, 4(2), 143-146.
40. Sandelowski, M. (1995). Sample size in qualitative methods. Research in Nursing & Health, 18(2), 179-183.
41. Sherman, S. L. (2000). Premature ovarian failure in the fragile X syndrome. American Journal of Medical Genetics, 97, 189-194.
42. Sherman, S.; Pletcher, B. A.; & Driscoll, D. A. (2005). Fragile X syndrome: diagnostic and carrier testing. Genetics in Medicine, 7(8), 584-587.
43. Sherrod, R. A. (2006). Male infertility: the element of disguise. Journal of Psychosocial Nursing and Mental Health Services, 44(10), 30-37.
44. Skinner, D.; Choudhury, S.; Sideris, J.; Guarda, S.; Buansi, A.; Roche, M.; et al. (2011). Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project. Pediatrics, 127(6), e1455-e1463.
45. Speroff, L.; & Fritz, M. A. (2005). Clinical gynecologic endocrinology and infertility (7th ed.). Philadelphia: Lippincott Williams & Wilkins.
46. Steeves, R. H.; & Kahn, D. L. (1995). A hermeneutical human science for nursing. In A. Omery, C. Kasper, & G. G. Page (Eds.), In search of nursing science. Beverly Hills: Sage.
47. Streuli, I.; Fraisse, T.; Ibecheole, V.; Moix, I.; Morris, M. A.; & de Ziegler, D. (2009). Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertility and Sterility, 92(2), 464-470.
48. Vits, L.; De Boulle, K.; Reyniers, E.; Handig, I.; Darby, J. K.; Oostra, B.; et al. (1994). Apparent regression of the CGG repeat in FMR1 to an allele of normal size. Human Genetics, 94(5), 523-526.
49. Whiteford, L. M.; & Gonzalez, L. (1995). Stigma: the hidden burden of infertility. Social Science & Medicine, 40(1), 27-36.
50. Wilkes, S.; Hall, N.; Crosland, A.; Murdoch, A.; & Rubin, G. (2009). Patient experience of infertility management in primary care: an in-depth interview study. Family Practice, 26(4), 309-316.
51. Wittenberger, M. D.; Hagerman, R. J.; Sherman, S. L.; McConkie-Rosell, A.; Welt, C. K.; Rebar, R. W.; et al. (2007). The FMR1 premutation and reproduction. Fertility and Sterility, 87(3), 456-465.
52. Yanushpolsky, E. H.; Hurwitz, S.; Tikh, E.; & Racowsky, C. (2003). Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in women younger than 40 years of age. Fertility & Sterility, 80(1), 111-115.
53. Zeesman, S.; Zwaigenbaum, L.; Whelan, D. T.; Hagerman, R. J.; Tassone, F.; & Taylor, S. A. M. (2004). Paternal transmission of fragile X syndrome. American Journal of Medical Genetics. Part A, 129A(2), 184-189.